Practice patterns and outcomes of endoscopic sleeve gastroplasty based on provider specialty

Abstract

Background and study aims Endoscopic sleeve gastroplasty (ESG) is performed in clinical practice by gastroenterologists and bariatric surgeons. Given the increasing regulatory approval and global adoption, we aimed to evaluate real-world outcomes in multidisciplinary practices involving bariatric surgeons and gastroenterologists across the United States.

Patients and methods We included adult patients with obesity who underwent ESG from January 2013 to August 2022 in seven academic and private centers in the United States. Patient and procedure characteristics, serious adverse events (SAEs), and weight loss outcomes up to 24 months were analyzed. SPSS (version 29.0) was used for all statistical analyses.

Results A total of 1506 patients from seven sites included 235 (15.6%) treated by surgeons and 1271 (84.4%) treated by gastroenterologists. There were no baseline differences between groups. Gastroenterologists used argon plasma coagulation for marking significantly more often than surgeons (P<0.001). Surgeons placed sutures in the fundus in all instances whereas gastroenterologist placed them in the fundus in less than 1% of the cases (P<0.001>). Procedure times were significantly different between groups, with surgeons requiring approximately 20 minutes more during the procedure than gastroenterologists (P<0.001). Percent total body weight loss (%TBWL) and percent responders achieving >10 and >15% TBWL were similar between the two groups at 12, 18, and 24 months. Rates of SAEs were low and similar at 1.7% for surgeons and 2.7% for gastroenterologists (P>0.05).

Conclusions Data from a large US cohort show significant and sustained weight loss with ESG and an excellent safety profile in both bariatric surgery and gastroenterology practices, supporting the scalability of the procedure across practices in a multidisciplinary setting.

Keywords

GI surgery - Endoscopy Upper GI Tract - Quality and logistical aspects - Performance and complications

Publication History

Received: 10 September 2023

Accepted after revision: 05 January 2024

Accepted Manuscript online:
22 January 2024

Article published online:
15 February 2024

• References

• 1 Gouni-Berthold I, Berthold HK. Current options for the pharmacotherapy of obesity. Curr Pharm Des 2019; 25: 2019-2032 DOI: 10.2174/1381612825666190708192630. (PMID: 31298150)
• 2 Wilding JPH, Batterham RL, Davies M. et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes Obes Metab 2022; 24: 1553-1564 DOI: 10.1111/dom.14725. (PMID: 35441470)
• 3 Martin M, Beekley A, Kjorstad R. et al. Socioeconomic disparities in eligibility and access to bariatric surgery: a national population-based analysis. Surg Obes Relat Dis 2010; 6: 8-15 DOI: 10.1016/j.soard.2009.07.003. (PMID: 19782647)
• 4 Campos GM, Khoraki J, Browning MG. et al. Changes in utilization of bariatric surgery in the United States from 1993 to 2016. Ann Surg 2020; 271: 201-209
• 5 Hedjoudje A, Abu Dayyeh BK, Cheskin LJ. et al. Efficacy and safety of endoscopic sleeve gastroplasty: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2020; 18: 1043-1053 DOI: 10.1016/j.cgh.2019.08.022. (PMID: 31442601)
• 6 Kumar N, Dayyeh BA, Dunkin BJ. et al. ABE/ASGE position statement on training and privileges for primary endoscopic bariatric therapies. Gastrointest Endosc 2020; 91: 1230-1233 DOI: 10.1016/j.gie.2019.07.017. (PMID: 31558279)
• 7 Evans JA, Muthusamy VR. American Society for Gastrointestinal Endoscopy Standards of Practice Committee. et al. The role of endoscopy in the bariatric surgery patient. Gastrointest Endosc 2015; 81: 1063-1072
• 8 Brunaldi VO, Neto MG. Endoscopic sleeve gastroplasty: a narrative review on historical evolution, physiology, outcomes, and future standpoints. Chin Med J (Engl) 2022; 135: 774-778 DOI: 10.1097/CM9.0000000000002098. (PMID: 35671178)
• 9 American College of Cardiology/American Heart Association Task Force on Practice Guidelines Obesity Expert Panel. Executive summary: Guidelines (2013) for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Obesity Society published by the Obesity Society and American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Based on a systematic review from the Obesity Expert Panel, 2013. Obesity (Silver Spring) 2014; 22: S5-S39
• 10 Elariny H, Gonzalez H, Wang B. Tissue thickness of human stomach measured on excised gastric specimens from obese patients. Surg Technol Int 2005; 14: 119-124 (PMID: 16525963)
• 11 James TW, McGowan CE. The descending gastric fundus in endoscopic sleeve gastroplasty: implications for procedural technique and adverse events. Videogastroenterologist 2019; 4: 254-255 DOI: 10.1016/j.vgie.2019.03.009. (PMID: 31193897)
• 12 Farha J, McGowan C, Hedjoudje A. et al. Endoscopic sleeve gastroplasty: suturing the gastric fundus does not confer benefit. Endoscopy 2021; 53: 727-731
• 13 Abu Dayyeh BK, Acosta A, Camilleri M. et al. Endoscopic sleeve gastroplasty alters gastric physiology and induces loss of body weight in obese individuals. Clin Gastroenterol Hepatol 2017; 15: 37-43 DOI: 10.1016/j.cgh.2015.12.030. (PMID: 26748219)
• 14 Spota A, Laracca GG, Perretta S. Training in bariatric and metabolic endoscopy. Ther Adv Gastrointest Endosc 2020; 13: 2631774520931978 DOI: 10.1177/2631774520931978. (PMID: 32596663)
• 15 Fonseca AL, Reddy V, Yoo PS. et al. Senior surgical resident confidence in performing flexible endoscopy: What can we do differently?. J Surg Educ 2016; 73: 311-316
• 16 Nass KJ, Zwager LW, Vlugt M van der. et al. Novel classification for adverse events in gastroenterologist endoscopy: the AGREE classification. Gastrointest Endosc 2022; 95: 1078-1085
• 17 Gudur AR, Geng C, Hallowell P. et al. Impact of proceduralist specialty on outcomes following endoscopic sleeve gastroplasty. Obes Surg 2022; 32: 3714-3721 DOI: 10.1007/s11695-022-06282-8. (PMID: 36169909)
• 18 Faulx AL, Lightdale JR. Committee ASGE Standards of Practice Committee. et al. Guidelines for privileging, credentialing, and proctoring to perform gastroenterologist endoscopy. Gastrointest Endosc 2017; 85: 273-281
• 19 Saumoy M, Schneider Y, Zhou XK. et al. A single-operator learning curve analysis for the endoscopic sleeve gastroplasty. Gastrointest Endosc 2018; 87: 442-447 DOI: 10.1016/j.gie.2017.08.014. (PMID: 28843586)
• 20 Neto MG, Silva LB, Quadros LG de. et al. Brazilian consensus on endoscopic sleeve gastroplasty. Obes Surg 2021; 31: 70-78 DOI: 10.1007/s11695-020-04915-4. (PMID: 32815105)
• 21 Alqahtani AR, Elahmedi M, Aldarwish A. et al. Endoscopic gastroplasty versus laparoscopic sleeve gastrectomy: a noninferiority propensity score-matched comparative study. Gastrointest Endosc 2022; 96: 44-50 DOI: 10.1016/j.gie.2022.02.050. (PMID: 35248571)
• 22 Sharaiha RZ, Hajifathalian K, Kumar R. et al. Five-year outcomes of endoscopic sleeve gastroplasty for the treatment of obesity. Clin Gastroenterol Hepatol 2021; 19: 1051-1057 DOI: 10.1016/j.cgh.2020.09.055. (PMID: 33011292)
• 23 Roser P, Bajaj SS, Stanford FC. International lack of equity in modern obesity therapy: the critical need for change in health policy. Int J Obes (Lond) 2022; 46: 1571-1572 DOI: 10.1038/s41366-022-01176-2. (PMID: 35778480)
• 24 Abu Dayyeh BK, Bazerbachi F, Vargas EJ. et al. Endoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity (MERIT): a prospective, multicentre, randomised trial. Lancet 2022; 400: 441-451 DOI: 10.1016/S0140-6736(22)01280-6. (PMID: 35908555)